These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in non-abstinent chronic alcoholics. Relation to clinical parameters. Lykouras E; Moussas G; Markianos M Drug Alcohol Depend; 1987 Jul; 19(4):363-8. PubMed ID: 3608795 [TBL] [Abstract][Full Text] [Related]
23. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients]. Xavier Vieira R; Azevedo M; Polónio P; Manso C Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081 [No Abstract] [Full Text] [Related]
24. Platelet monoamine oxidase in schizophrenia: a meta-analysis. Marcolin MA; Davis JM Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426 [TBL] [Abstract][Full Text] [Related]
25. [Determination of monoamine oxidase and catechol-O-methyltransferase in human blood components: methodical aspects (author's transl)]. Christ W; Rakow D; Honecker H; Coper H Arzneimittelforschung; 1976; 26(6):1151-2. PubMed ID: 989404 [TBL] [Abstract][Full Text] [Related]
27. The effects of testosterone on plasma and platelet monoamine oxidase (MAO) an plasma dopamine-beta-hydroxylase (DBH) activities in the male rhesus monkey. Redmond DE; Baulu J; Murphy DL; Loriaux DL; Zeigler MG; Lake CR Psychosom Med; 1976; 38(5):315-26. PubMed ID: 824661 [TBL] [Abstract][Full Text] [Related]
29. Platelet monoamine oxidase and clinical phenomenology of schizophrenia. Baron M; Gruen R; Levitt M; Kane J Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413 [TBL] [Abstract][Full Text] [Related]
30. Measurement of platelet monoamine oxidase using three different substrates in patients with alcoholism and schizophrenia. Tsuji M Folia Psychiatr Neurol Jpn; 1985; 39(4):521-30. PubMed ID: 3833630 [TBL] [Abstract][Full Text] [Related]
31. Blood platelet monoamine oxidase activity in anergic schizophrenics. Shaskan EG; Becker RE Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):29-35. PubMed ID: 1233383 [TBL] [Abstract][Full Text] [Related]
32. Menstrual cycle and ovarian hormone effects on plasma and platelet monoamine oxidase (MAO) and plasma dopamine-beta-hydroxylase (DBH) activities in the rhesus monkey. Redmond DE; Murphy DL; Baulu J; Ziegler MG; Lake CR Psychosom Med; 1975; 37(5):417-28. PubMed ID: 808811 [TBL] [Abstract][Full Text] [Related]
33. Platelet monoamine oxidase activity: relation to genetic load of schizophrenia. Baron M; Levitt M Psychiatry Res; 1980 Sep; 3(1):69-74. PubMed ID: 6934558 [TBL] [Abstract][Full Text] [Related]
34. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. II. Erythrocyte catechol-O-methyltransferase activity in endogenous depression. Puzynski S; Bidzinski A; Mrozek S; Zaluska M Acta Psychiatr Scand; 1983 Feb; 67(2):96-100. PubMed ID: 6846043 [TBL] [Abstract][Full Text] [Related]
35. Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity. Goldin LR; Gershon ES; Lake CR; Murphy DL; McGinniss M; Sparkes RS Am J Hum Genet; 1982 Mar; 34(2):250-62. PubMed ID: 6951409 [TBL] [Abstract][Full Text] [Related]
36. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients. Owen F; Bourne R; Crow TJ; Johnstone EC; Bailey AR; Hershon HI Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182 [TBL] [Abstract][Full Text] [Related]
37. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs. Kemali D; Maj M; Ariano MG; Salvati A Encephale; 1985; 11(1):31-4. PubMed ID: 2859981 [TBL] [Abstract][Full Text] [Related]